• Profile
Close

Application of the 2017 revised McDonald criteria for multiple sclerosis to patients with a typical clinically isolated syndrome

JAMA Neurology Aug 10, 2018

van der Vuurst de Vries RM, et al. - Researchers sought to validate the new diagnostic criteria proposed in 2017 for multiple sclerosis (MS) in patients with a typical clinically isolated syndrome (CIS) by comparing the diagnostic accuracy of the 2017 criteria vs the 2010 criteria in prediction of clinically definite MS. The 2017 revised McDonald criteria displayed a higher sensitivity but a lower specificity for a second attack. These criteria lead to a higher number of MS diagnoses in patients with a less active disease course.

Methods

  • Researchers included 251 patients at Erasmus MC, Rotterdam, the Netherlands, in collaboration with several regional hospitals.
  • Early in the diagnostic process, 13 patients received another diagnosis and were excluded from the analyses, while 9 patients with CIS did not want to participate in the study.
  • In this prospective CIS cohort, 229 patients were left who were included between March 2006 and August 2016.
  • Within 3 months after onset of symptoms, patients underwent a baseline magnetic resonance imaging scan and, if clinically required, had a lumbar puncture.
  • From December 2017 and January 2018, they performed data analysis.
  • Calculation of sensitivity, specificity, accuracy, and positive and negative predictive value was performed after 1, 3, and 5 years for the 2017 vs the 2010 criteria.

Results

  • Women comprised 73% (n=167) of the 229 patients with CIS; the mean (SD) age was 33.5 (8.2) years.
  • CDMS was diagnosed in 113 (49%) patients during a mean (SD) follow-up time of 65.3 (30.9) months.
  • The 2017 criteria had higher sensitivity (68%; 95% CI, 57%-77% vs 36%; 95% CI, 27%-47%; P < .001), but lower specificity compared to the 2010 criteria (61%; 95% CI, 50%-71% vs 85%; 95% CI, 76%-92%; P < .001).
  • More MS diagnoses were made at baseline using the 2017 criteria (n = 97 [54%]; 95% CI, 47%-61% vs n = 46 [26%]; 95% CI, 20%-32%; P < .001).
  • A second attack was not observed in 33% of patients who were diagnosed as having MS using the 2017 criteria during follow-up vs 23% when using the 2010 criteria, in the group with at least 5 years of follow-up.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay